CV Forum: Impactful Cardiovascular Studies in 2021
Recording Available Until:
September 27, 2022
Program Overview
This webinar was recorded on September 27, 2021.
The Monthly Cardiovascular Forum represents a unique multidisciplinary collaboration between cardiologists, vascular, and cardiac surgeons, allowing for a truly comprehensive approach to the management of aortic and cardiovascular disease. Lectures, case presentations and panel discussions will be given by internationally recognized experts who will address the updated knowledge and cutting-edge technologies in the field, and review standard and emerging treatments for patients with cardiovascular diseases.
The Monthly Cardiovascular Forum represents a unique multidisciplinary collaboration between cardiologists, vascular, and cardiac surgeons, allowing for a truly comprehensive approach to the management of aortic and cardiovascular disease. Lectures, case presentations and panel discussions will be given by internationally recognized experts who will address the updated knowledge and cutting-edge technologies in the field, and review standard and emerging treatments for patients with cardiovascular diseases.
September 27 2021: Impactful Cardiovascular Studies in 2021
This month, we will review two impactful cardiovascular studies: (1) Left Atrial Appendage Occlusion Study (LAAOS) and Mavacamten for HOCM. Join our panel members for a timely and interesting discussion.
This month, we will review two impactful cardiovascular studies: (1) Left Atrial Appendage Occlusion Study (LAAOS) and Mavacamten for HOCM. Join our panel members for a timely and interesting discussion.
Learning Objectives
- Discuss the results of the Left Atrial Appendage Occlusion Trial
- Review Mavacamten Trial for HOCM
Target Audience
This
activity is designed for primary care physicians, cardiologists, interventional
cardiologists, vascular, thoracic and cardiac surgeons, general surgeons,
internists, intensivists, anesthesiologists, podiatrists, cardiac and vascular
NPs and PAs, physical therapists and other medical professionals involved in
the evaluation, diagnosis, and/or management of patients with cardiovascular
disease.
Method of Participation
Once you register, you will receive an email with a link to access the recording.
Agenda
Monday, September 27
7:00 AM
7:00 AM
Welcome Remarks from our Moderators: Hiroo Takayama, MD, PhD & Isaac George, MD
7:05 AM
7:05 AM
Study 1: Presentation & Panel Discussion: Surgical Left Atrial Appendage Closure Trial
7:35 AM
7:35 AM
Study 2: Presentation & Panel Discussion: Mavacamten for HOCM
8:00 AM
8:00 AM
Closing Remarks: Hiroo Takayama, MD, PhD
Participating Faculty
Associate Professor of Surgery Surgical Director of the Heart Valve Center at Columbia Surgical Director, Structural Heart Disease, NYP
Associate Professor of Medicine at CUIMC Director of Research, Hypertrophic Cardiomyopathy Center
Associate Professor of Medicine at CUIMC Medical Director of the Hypertrophic Cardiomyopathy Center
No records found.